Vaccines Market 2018: Exploration on Eminent Players | AstraZeneca, Abbott, Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, Sanofi Pasteur, Pfizer, GlaxoSmithKline, Emergent BioSolutions, Astellas Pharma, CSL, Novavax

Global Vaccines Market size was valued over USD 32 billion in 2016 and is expected to witness more than 9% CAGR from 2017 to 2024.

Rising prevalence of several infectious and non-infectious diseases globally coupled with increasing funding for vaccine development will drive the vaccines market size. Growing demand for preventive vaccines, rising awareness coupled with mounting demand among the developing countries should boost the business revenue.

Immunization currently prevents an estimated 2 to 3 million deaths every year. Furthermore, additional 1.5 million deaths could be evaded through improved global vaccination coverage. Increasing uptake of new and underused vaccines will prominently intensify its global usage over the forecast years.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/2186

Technological advances, rising demand for low cost products and widespread routine vaccination programmes in emerging economies will stimulate the business growth. Increasing demand for combined vaccines that offers immunization against several diseases, growing initiatives for production of low cost vaccines will further boost the industry growth.

Pediatric will grow at a significant rate over the forecast period owing to CDC recommendation for immunization schedule to protect children and infants before getting exposed to potentially life-threatening diseases.

Attenuated vaccines will grow at a substantial rate over the forecast period pertaining to factors such as robust antibody and cellular responses, and frequently deliberate lifelong immunity with only one or two doses.

Influenza will witness considerable growth due to growing incidence, mounting number of disease-causing microbes (pathogens) and rising awareness in emerging economies towards disease prevention. Availability of vaccines at affordable prices in hospitals and clinics will augment the segment growth.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/2186

U.S. vaccines market will witness significant growth over the forecast period pertaining to enormous impact of immunization on improving health of children and protecting them with vaccines due to epidemics of preventable diseases like mumps, pertussis, and measles.

India will witness lucrative growth due to improved efficiency of immunization programs and technological advancements in vaccine storage and transport. Rising per capita income, improved healthcare infrastructure and growing healthcare expenditure will promote business growth.

China vaccines market will grow at a substantial rate owing to rising disposable income, rapid economic growth, rising number of unvaccinated migrant workers, and delivery of efficient healthcare services.

Brazil vaccines market will growth at a considerable rate over the coming years. Availability of vaccines at low cost and rising initiatives by Brazilian government to improve vaccination coverage will stimulate steady business expansion.

Some of the companies operating in industry are Abbott, AstraZeneca, Astellas Pharma, Bristol-Myers Squibb, CSL, Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Novavax, Pfizer and Sanofi Pasteur.

New product launches and expansion of existing product portfolio will mainly drive the business growth. Major industry participants will endeavor to fortify their market position by adopting these strategies.

Report Content

Chapter 1. Methodology
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical modeling and forecast
1.1.3. Industry insights and validation
1.1.4. Market definition and forecast assumptions
1.2. Data sources
1.2.1. Primary
1.2.2. Secondary

Chapter 2. Executive Summary
2.1. Global Vaccines industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Age group trends
2.1.3. Disease trends
2.1.4. Technology trends
2.1.5. Regional trends

Chapter 3. Vaccines Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing government funding for vaccine development
3.3.1.2. Increasing vaccines R&D in developed nations
3.3.1.3. Increasing disease prevalence in underdeveloped countries
3.3.1.4. Growing incidences of cancer & HIV in Asia Pacific
3.3.2. Industry pitfalls & challenges
3.3.2.1. High cost of vaccine storage and transportation
3.3.2.2. Stringent regulations for the approval of vaccines in developed nations
3.4. Growth potential analysis
3.4.1. By age group
3.4.2. By technology
3.4.3. By disease
3.5. Regulatory landscape
3.5.1. U.S
3.5.2. Europe
3.5.3. Asia Pacific
3.6. Reimbursement scenario
3.6.1. U.S
3.6.2. Europe
3.7. Technology landscape
3.8. Pricing analysis
3.9. Pipeline product analysis
3.9.1. Malaria
3.9.2. HIV
3.9.3. Zika
3.9.4. Ebola
3.10. Porter’s analysis
3.11. Company market share analysis, 2016
3.11.1. Strategy dashboard
3.12. PESTEL analysis

Chapter 4. Vaccines Market, By Age group
4.1. Global vaccines market share by age group, 2016 & 2024
4.2. Pediatric
4.2.1. Market estimates and forecast, by region, 2013 - 2024
4.3. Adult
4.3.1. Market estimates and forecast, by region, 2013 - 2024

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.